• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about ABBV

    Recent news which mentions ABBV

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    32 33 Next >
    Behind the Scenes of AbbVie's Latest Options Trends
    Tickers ABBV
    Tags ABBV Benzinga Options
    From Benzinga
    Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
    Tickers ABBV GSK NEWS NVO
    Tags medicare Market News NVO
    From Benzinga
    5 Best Dividend Growth Stocks to Buy in October
    Tickers ABBV AXP BAC COST
    Tags BAC MSFT Market News
    From Motley Fool
    Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
    Tickers ABBV ACN DIS META
    Tags Halftime Report Final Trades Kevin Simpson CNBC
    From Benzinga
    (ABBV) - Analyzing AbbVie's Short Interest
    Tickers ABBV
    Tags BZI/SHORTHIST Short Ideas Market News
    From Benzinga
    Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
    Tickers ABBV BMY NEWS
    Tags why it's moving News Briefs
    From Benzinga
    Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
    Tickers ABBV NEWS
    Tags News Market News Benzinga
    From Benzinga
    AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
    Tickers ABBV NEWS
    Tags ABBV General Health Care
    From Benzinga
    Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
    Tickers ABBV NVO
    Tags Market News ABBV Recent Press Releases
    From Motley Fool
    Behind the Scenes of AbbVie's Latest Options Trends
    Tickers ABBV
    Tags BZI/UOA Markets Market News
    From Benzinga
    Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
    Tickers ABBV BMY NEWS
    Tags Top Stories Market News Stories That Matter
    From Benzinga
    Spotlight on AbbVie: Analyzing the Surge in Options Activity
    Tickers ABBV
    Tags Market News Markets BZI/UOA
    From Benzinga
    Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
    Tickers ABBV NEWS
    Tags Trading Ideas Benzinga ABBV
    From Benzinga
    2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
    Tickers ABBV AZN
    Tags Market News AZN ABBV
    From Motley Fool
    TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
    Tickers ABBV BJ NEWS SMH
    Tags BJ TDG Jason Snipe
    From Benzinga
    Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
    Tickers ABBV ABT
    Tags ABBV Recent Press Releases Market News
    From Motley Fool
    Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
    Tickers ABBV MRNA
    Tags MRNA Market News ZLDP/F
    From Motley Fool
    3 Stocks to Buy and Hold Forever
    Tickers ABBV ABT LLY VRTX
    Tags Market News ABT ABBV
    From Motley Fool
    Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
    Tickers ABBV BIP BIPC VZ
    Tags ABBV Recent Press Releases BIP
    From Motley Fool
    Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
    Tickers ABBV
    Tags Recent Press Releases ABBV Market News
    From Motley Fool
    UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
    Tickers ABBV ALVO AMGN CI
    Tags TEVA Health Care Biotech
    From Benzinga
    What the Options Market Tells Us About AbbVie
    Tickers ABBV
    Tags Options Benzinga ABBV
    From Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    32 33 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.